CPhI Worldwide 2013 Hosted More Than 34,000 Global Pharma Professionals
News Nov 26, 2013
CPhI Worldwide celebrates the closing of its most successful show to date with pre-audit figures estimating more than 34,000 attendees and 2,200 exhibitors.
Held in Frankfurt, the show hosted senior-level decision makers and key players from 140+ countries representing every step of the pharmaceutical supply chain from drug discovery to finished dosage.
On Monday, CPhI Conferences hosted the Pre-Connect with 6 modules on themes including drug delivery systems and biosimilars. The conference featured senior executives and influential industry speakers from Bayer, Novartis and Wockhardt, who leveraged their expertise and insight to educate the industry.
Throughout the week, free content was available in the exhibition with sessions covering Ingredients, Contract Services, Packaging, Animal Health, Biopharma and Natural Extracts, Innovation Tours on biopharma and packaging, and Lunch Briefings on emerging markets of India and Brazil.
With 4 different exhibitions in one (CPhI, P-MEC, InnoPack and ICSE) the event has become the world’s melting pot and key point of the year to complete new deals, see innovative technologies and meet potential partners- attendees say it’s invaluable to the industry.
This year’s event held a record of 17 global pavilions to highlight different countries from each continent- including China, India, USA and Brazil amongst others.
The winners of the 2013 CPhI Pharma Awards were announced, honouring innovation across three categories (Best Innovation in Formulation, Packaging and Process Development) which went to Camurus, E-Pharma Trento and API Corporation, respectively.
Another major addition to this year’s show was the introduction of CPhI Pharma Evolution- a new community website launched in February to help professionals from the pharma industry to share advice from their peers on best-practices and regulatory changes across the pharmaceutical ingredient and contract manufacturing space.
The site features a wealth of stories covering the huge amounts of activity across all four days of the show, including news on all the major initiatives and company news announced. For more information, please visit: www.pharmevolution.com.
CPhI Worldwide and CPhI Pharma Evolution were pleased to release its first Annual Report during the event. Written by a panel of industry experts, the report highlighted key trends including QbD, PAT and six sigma in a series of forward looking articles.
Chris Kilbee, Group Director of CPhI, commented: “This year’s event has been a great success with exhibitors reporting quality meetings and promising business opportunities coming out of the event. We’re pleased to expand our content offering this year with seminars, innovation tours and the release of the first Annual Report. As the pharmaceutical market continues to grow and expand, CPhI will adapt and evolve to deliver industry insights and continue to provide the best platform for developing contacts as the event returns to Paris for its 25th edition from 7–9 October 2014.”
PhoreMost and Plexxikon Collaborate to Identify Novel Drug TargetsNews
PhoreMost, the UK-based biopharmaceutical company dedicated to drugging ‘undruggable’ disease targets, today announced it has signed a collaborative agreement with Plexxikon Inc., the small molecule structure-guided R&D centre of Daiichi Sankyo.READ MORE
Lonza Opens World’s Largest Dedicated Cell-and-Gene-Therapy Manufacturing Facility in TexasNews
First-of-its-kind, state-of-the-art manufacturing facility with capacity to produce treatment for thousands of patients suffering from rare genetic disorders or life-threatening diseases.READ MORE
IONTAS and IGEM Therapeutics Collaborate to Identify Novel IgE AntibodiesNews
The project will add to IGEM’s pipeline of drugs and expand upon IGEM-F, an IgE targeting ovarian and other cancers, currently in a Phase 1/2a study.READ MORE